Immune Thrombocytopenia (ITP): Adult Perspective

Immune thrombocytopenia (ITP) is an important clinical entity with a mortality rate of about 5% and is notoriously chronic in adult population. Since it is a diagnosis of exclusion, it becomes very important for the clinicians to follow recent guidelines regarding the diagnosis, categorisation and treatment of this clinical entity, so as to reduce the morbidity and mortality. This article provides the insight into understanding the pathophysiological and management aspects of this clinical entity in the light of recent changes and advances that have taken place over the recent past. How to define and categorise ITP, how to search for the possible cause, which drug to use and when to use it, are a few of the issues, which have been addressed in this article.